Island Advances Galidesivir GMP Manufacturing for Biodefence
Filed with ASX · · 3 pages · English
Island Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Island Pharmaceuticals
- Island Adds Biodefence Leader as Filovirus Risks Escalate
- Island Bolsters US Biodefence Readiness Ahead of Trials
- Antiviral pipeline expansion through strategic collaboration
- US Government collaboration for Galidesivir development
- Trading Halt
Later from Island Pharmaceuticals
- Island Secures USAMRIID Support for Galidesivir Study
- Investor presentation
- Investor Presentation - Asia Dengue Summit
- FDA Grants Orphan Designation for Galidesivir in Marburg
- Singapore Patent Expands Island's ISLA 101 Viral Protection
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals